168 related articles for article (PubMed ID: 15988765)
1. Partial protection against Botulinum B neurotoxin-induced blocking of exocytosis by a potent inhibitor of its metallopeptidase activity.
Anne C; Turcaud S; Blommaert AG; Darchen F; Johnson EA; Roques BP
Chembiochem; 2005 Aug; 6(8):1375-80. PubMed ID: 15988765
[TBL] [Abstract][Full Text] [Related]
2. Botulinum neurotoxin serotype F: identification of substrate recognition requirements and development of inhibitors with low nanomolar affinity.
Schmidt JJ; Stafford RG
Biochemistry; 2005 Mar; 44(10):4067-73. PubMed ID: 15751983
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
Sharma SK; Singh BR
Biochemistry; 2004 Apr; 43(16):4791-8. PubMed ID: 15096048
[TBL] [Abstract][Full Text] [Related]
4. High-throughput fluorogenic assay for determination of botulinum type B neurotoxin protease activity.
Anne C; Cornille F; Lenoir C; Roques BP
Anal Biochem; 2001 Apr; 291(2):253-61. PubMed ID: 11401299
[TBL] [Abstract][Full Text] [Related]
5. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.
Blasi J; Chapman ER; Link E; Binz T; Yamasaki S; De Camilli P; Südhof TC; Niemann H; Jahn R
Nature; 1993 Sep; 365(6442):160-3. PubMed ID: 8103915
[TBL] [Abstract][Full Text] [Related]
6. Small tripeptide surrogates with low nanomolar affinity as potent inhibitors of the botulinum neurotoxin B metallo-proteolytic activity.
Blommaert A; Turcaud S; Anne C; Roques BP
Bioorg Med Chem; 2004 Jun; 12(11):3055-62. PubMed ID: 15142564
[TBL] [Abstract][Full Text] [Related]
7. Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity.
Jin R; Rummel A; Binz T; Brunger AT
Nature; 2006 Dec; 444(7122):1092-5. PubMed ID: 17167421
[TBL] [Abstract][Full Text] [Related]
8. Development of potent inhibitors of botulinum neurotoxin type B.
Anne C; Turcaud S; Quancard J; Teffo F; Meudal H; Fournié-Zaluski MC; Roques BP
J Med Chem; 2003 Oct; 46(22):4648-56. PubMed ID: 14561084
[TBL] [Abstract][Full Text] [Related]
9. Thio-derived disulfides as potent inhibitors of botulinum neurotoxin type B: implications for zinc interaction.
Anne C; Blommaert A; Turcaud S; Martin AS; Meudal H; Roques BP
Bioorg Med Chem; 2003 Oct; 11(21):4655-60. PubMed ID: 14527562
[TBL] [Abstract][Full Text] [Related]
10. [Tetanus and botulinum toxins are zinc metallopeptidases: molecular mechanisms and inhibition of their neurotoxicity].
Cornille F; Roques BP
J Soc Biol; 1999; 193(6):509-16. PubMed ID: 10783709
[TBL] [Abstract][Full Text] [Related]
11. [Mechanisms of action of botulinum toxins and neurotoxins].
Poulain B; Lonchamp E; Jover E; Popoff MR; Molgó J
Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S73-6. PubMed ID: 19576489
[TBL] [Abstract][Full Text] [Related]
12. Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential.
Meng J; Wang J; Lawrence G; Dolly JO
J Cell Sci; 2007 Aug; 120(Pt 16):2864-74. PubMed ID: 17666428
[TBL] [Abstract][Full Text] [Related]
13. Poisoning by botulinum neurotoxin A does not inhibit formation or disassembly of the synaptosomal fusion complex.
Otto H; Hanson PI; Chapman ER; Blasi J; Jahn R
Biochem Biophys Res Commun; 1995 Jul; 212(3):945-52. PubMed ID: 7626135
[TBL] [Abstract][Full Text] [Related]
14. Tetanus and botulinum neurotoxins: turning bad guys into good by research.
Rossetto O; Seveso M; Caccin P; Schiavo G; Montecucco C
Toxicon; 2001 Jan; 39(1):27-41. PubMed ID: 10936621
[TBL] [Abstract][Full Text] [Related]
15. Activity-dependent changes in partial VAMP complexes during neurotransmitter release.
Hua SY; Charlton MP
Nat Neurosci; 1999 Dec; 2(12):1078-83. PubMed ID: 10570484
[TBL] [Abstract][Full Text] [Related]
16. Location of the synaptosome-binding regions on botulinum neurotoxin B.
Dolimbek BZ; Steward LE; Aoki KR; Atassi MZ
Biochemistry; 2012 Jan; 51(1):316-28. PubMed ID: 22146011
[TBL] [Abstract][Full Text] [Related]
17. Central effects of tetanus and botulinum neurotoxins.
Caleo M; Schiavo G
Toxicon; 2009 Oct; 54(5):593-9. PubMed ID: 19264088
[TBL] [Abstract][Full Text] [Related]
18. Natural Compounds and Their Analogues as Potent Antidotes against the Most Poisonous Bacterial Toxin.
Patel KB; Cai S; Adler M; Singh BK; Parmar VS; Singh BR
Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30389764
[TBL] [Abstract][Full Text] [Related]
19. Longer-acting and highly potent chimaeric inhibitors of excessive exocytosis created with domains from botulinum neurotoxin A and B.
Wang J; Zurawski TH; Bodeker MO; Meng J; Boddul S; Aoki KR; Dolly JO
Biochem J; 2012 May; 444(1):59-67. PubMed ID: 22360156
[TBL] [Abstract][Full Text] [Related]
20. [Clostridium botulinum and botulinum neurotoxin].
Hirai Y
Brain Nerve; 2011 Jul; 63(7):755-61. PubMed ID: 21747146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
